Catalyst Pharm Inc (CPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,888 | -1,744 | -4,076 | -4,000 | -1,378 |
| Depreciation Amortization | 11 | 5 | 11 | 8 | 6 |
| Accounts payable and accrued liabilities | -917 | -799 | 1,102 | 92 | -41 |
| Other Working Capital | 185 | -597 | -285 | 20 | -112 |
| Other Operating Activity | 1,548 | 886 | -1,892 | 333 | -920 |
| Operating Cash Flow | $-4,061 | $-2,249 | $-5,140 | $-3,547 | $-2,446 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 1,022 | -3 | -7,504 | 0 | N/A |
| PPE Investments | -9 | -9 | -52 | -7 | -7 |
| Other Investing Activity | 2,495 | 1,497 | -6,503 | 0 | 0 |
| Investing Cash Flow | $3,507 | $1,485 | $-14,060 | $-7 | $-7 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 0 | 5,000 | N/A | N/A |
| Common Stock Issued | 24 | 0 | 9,581 | 9,498 | 3,938 |
| Financing Cash Flow | $24 | $N/A | $14,581 | $9,498 | $3,938 |
| Beginning Cash Position | 1,410 | 1,410 | 6,029 | 6,029 | 6,029 |
| End Cash Position | 879 | 646 | 1,410 | 11,974 | 7,515 |
| Net Cash Flow | $-531 | $-764 | $-4,619 | $5,945 | $1,486 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,061 | -2,249 | -5,140 | -3,547 | -2,446 |
| Capital Expenditure | -9 | -9 | -52 | -7 | -7 |
| Free Cash Flow | -4,071 | -2,259 | -5,193 | -3,554 | -2,453 |